Penalty Amount
$1,500,000
Consumers Affected
55,000,000
The FTC settled with GoodRx for sharing consumers' sensitive prescription and health information with Facebook, Google, and other third parties for advertising without consent, and for failing to report these unauthorized disclosures as required by the Health Breach Notification Rule. GoodRx will pay a $1.5 million civil penalty and is permanently barred from sharing user health data for advertising.
GoodRx must pay a $1.5 million penalty. It is permanently prohibited from sharing user health information with third parties for advertising. For any other sharing, it must obtain users' affirmative express consent. The company must direct third parties to delete the shared health data, inform consumers about the breaches, implement a comprehensive privacy program, limit data retention, and publicly post its data retention schedule.
In-house legal teams should review all agreements involving the handling of consumer health data, including vendor contracts with advertising platforms (e.g., Facebook, Google), customer terms of service, and data processing agreements. Specific clauses to scrutinize are those governing data sharing, consent mechanisms for advertising, breach notification procedures, and restrictions on the use of sensitive health information. Changes may be required to explicitly prohibit sharing user health data for advertising without prior opt-in consent, mandate prompt breach reporting under the Health Breach Notification Rule, and ensure all third-party data transfers comply with health privacy regulations.
Entity
GoodRx Holdings Inc.
Also known as: GoodRx
Industry
HealthcareOfficial Press Release
https://www.ftc.gov/news-events/news/press-releases/2023/02/ftc-enforcement-action-bar-goodrx-sharing-consumers-sensitive-health-info-advertising
goodrx complaint for permanent injunction civil penalties an
/system/files/ftc_gov/pdf/goodrx_complaint_for_permanent_injunction_civil_penalties_and_other_relief.pdf
goodrx stipulated order for permanent injunction civil penal
/system/files/ftc_gov/pdf/goodrx_stipulated_order_for_permanent_injunction_civil_penalty_judgment_and_other_relief.pdf
Federal Trade Commission Enforcement Page
https://www.ftc.gov/enforcement
"GoodRx Holdings Inc."
"pay a $1.5 million civil penalty"
"sharing sensitive personal health information—including its users’ prescription medications and personal health conditions—with third party advertising companies and advertising platforms like Facebook, Google, and Criteo"
"failed to notify consumers, the FTC, and the media about the company’s unauthorized disclosure of individually identifiable health information"
"prohibits the company from using manipulative designs, known as dark patterns, to obtain users’ consent"
"violating the Health Breach Notification Rule"
The FTC referred a complaint against REPS & Company Inc. and company executives, alleging they bypassed ticket-issuer security controls and purchasing limits to acquire millions of tickets for resale. The complaint was filed by the Department of Justice, and the case will be decided by the court; the press release does not report a penalty or other remedy imposed.
The FTC sued Digital Forensics Corporation LLC and affiliated defendants, alleging they misled sextortion victims with promises of investigative and monitoring services that often were not provided, and used fake positive reviews. A federal court granted the FTC’s request to temporarily halt the defendants’ activities; the complaint remains for the court to decide.
The FTC alleged that Greenway Auto Group advertised vehicle prices thousands of dollars below the amounts consumers actually paid and used mailers falsely suggesting recipients had won cash prizes. Greenway agreed to an order requiring transparent pricing and prohibiting deceptive prize mailers and other misrepresentations; the press release does not state a monetary penalty.
The FTC sent warning letters to 24 large healthcare services companies, cautioning that incomplete, inaccurate, or untimely pricing information for scheduled medical care may be unfair or deceptive. The letters urge recipients to review their price-disclosure practices and take corrective action; they announce no fine or formal order.
$1.9M
The FTC alleged that Premier Franchising Group LLC and Franchise Fastlane LLC made deceptive and unsubstantiated claims about the Premier Martial Arts franchise opportunity and violated the Franchise Rule. The proposed settlements require the companies to pay a combined $1.85 million to compensate franchisees, prohibit certain misrepresentations, and require Franchise Rule compliance; certain franchisees may also cancel their agreements without penalty.
The FTC, Utah, and Nevada sued Lens.com Inc., alleging that it advertised artificially low contact lens prices while hiding mandatory checkout charges and misleading consumers about its AutoRefill subscription. The complaint seeks to stop the alleged practices; the court has not yet decided the case, and no penalty or remedy has been imposed.